Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of leukemia inhibitory factor and endothelin antagonists

Use of leukemia inhibitory factor and endothelin antagonists

US Patent 6156733 · Granted Dec 5, 2000

Estimated economic value: $324,286,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting VEGF inhibitors for intraocular neovascularization2023
Methods and compositions for treatment of angiogenic disorders using anti-VEGF a2022
Long-acting VEGF inhibitors for intraocular neovascularization2022
Long-acting VEGF inhibitors for intraocular neovascularization2022
B7-H3L cell surface antigen and antibodies that bind thereto2017
Methods of inhibiting vascular endothelial growth factor activity2016
Anti-Bv8 antibodies and uses thereof2016
Compositions with hematopoietic and immune activity2014
B7-H3L cell surface antigen and antibodies that bind thereto2014
Anti-BV8 antibodies and uses thereof2014
Inhibitors of angiopoietin-like 4 protein, combinations, and their use2013
EG-VEGF nucleic acids and polypeptides and methods of use2013